Updated Jul 16, 2026
Ullem Scott B. has filed 5 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $3.79M.

Scott B. Ullem is a corporate executive known for his roles at Edwards Lifesciences Corp and Illumina, Inc., where he has served as Chief Financial Officer and Director. He has been involved in the financial management of these companies, contributing to their operations in the medical device and biotechnology sectors.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | ILMN | ILLUMINA, INC. | A — Grant or award | 167 | $149.19 | $25K |
| 2026-05-22 | ILMN | ILLUMINA, INC. | A — Grant or award | 2.1K | $144.83 | $300K |
| 2026-05-12 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 11.0K | $79.96 | $880K |
| 2026-05-12 | EW | Edwards Lifesciences Corp | M — Option exercise | 19.8K | $0.00 | |
| 2026-05-09 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 1.7K | $82.76 | $137K |
| 2026-05-09 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 1.4K | $83.20 | $114K |
| 2026-05-05 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 11.1K | $82.91 | $923K |
| 2026-05-05 | EW | Edwards Lifesciences Corp | M — Option exercise | 13.0K | $59.26 | $770K |
| 2026-05-05 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 620 | $83.98 | $52K |
| 2026-04-09 | EW | Edwards Lifesciences Corp | S — Open-market sale [10b5-1] | 8.3K | $79.79 | $664K |
| 2026-04-09 | EW | Edwards Lifesciences Corp | S — Open-market sale [10b5-1] | 4.7K | $80.50 | $376K |
| 2026-04-09 | EW | Edwards Lifesciences Corp | M — Option exercise [10b5-1] | 13.0K | $59.26 | $770K |
| 2026-04-02 | ILMN | ILLUMINA, INC. | A — Grant or award | 190 | $131.55 | $25K |
| 2026-03-11 | EW | Edwards Lifesciences Corp | S — Open-market sale [10b5-1] | 7.9K | $85.21 | $673K |
| 2026-03-11 | EW | Edwards Lifesciences Corp | S — Open-market sale [10b5-1] | 5.1K | $84.46 | $431K |
| 2026-03-11 | EW | Edwards Lifesciences Corp | M — Option exercise [10b5-1] | 13.0K | $59.26 | $770K |
| 2026-02-17 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 199 | $75.87 | $15K |
| 2026-01-05 | ILMN | ILLUMINA, INC. | A — Grant or award | 212 | $117.63 | $25K |
| 2025-09-30 | ILMN | ILLUMINA, INC. | A — Grant or award | 252 | $99.17 | $25K |
| 2025-06-30 | ILMN | ILLUMINA, INC. | A — Grant or award | 307 | $81.20 | $25K |
Scott B. Ullem is a corporate executive known for his roles at Edwards Lifesciences Corp and Illumina, Inc., where he has served as Chief Financial Officer and Director. He has been involved in the financial management of these companies, contributing to their operations in the medical device and biotechnology sectors.…
5 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($3.79M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ullem Scott B. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.